Latham Fund

Latham BioPharm Group (LBG) is a leading life sciences advisory firm that provides comprehensive strategic, technical, and operational services to the pharmaceutical and biotechnology industries. The company specializes in non-dilutive funding, helping clients secure and manage grants and contracts from government agencies such as BARDA, NIH, and DoD. In addition to funding support, LBG offers expertise in CMC, quality systems, regulatory affairs, and business development. The firm serves a diverse range of clients, from early-stage startups to large pharmaceutical companies, facilitating the development and commercialization of innovative medical countermeasures and therapeutics. In 2024, Latham BioPharm Group was acquired by Veristat, a global clinical research organization, to enhance its strategic consulting and non-dilutive funding capabilities.